藤本７号機／４１９‐４６２　プログラム

患者用冊子160524.indd

2 ... 4... 4... 6... 8... 10... 12... 14... 16... 21... 23... 25... 30... 32... 33... 33... 33... 34... 35... 36... 37... 38... 40... 41... 43... 48... 50... 58 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

2

2 ... 4... 4... 6... 8... 10... 12... 14... 19... 21... 23... 28... 30... 31... 31... 31... 32... 33... 34... 35... 36... 37... 39... 48... 50... 52 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

橡NO005-PDF用.ec5

(Biotechnology, Cell Biology, Genetics, Immunology, Medicine, Neuroscience, Structural Biology) (Cancer, Genetics, Immunology, Molecular Cell Biology, Neuroscience) InfoPort TEL: 043-290-2262 FAX:

がん患者の終末期ケアにおける通所リハビリテーションの役割　介護保険によるがん終末期ケアの可能性

2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4

1 2 1 1 3 Q&A Q A 4 1 1 5 6 1 1 2 3 1 2 1 7 1 2 1 2 8 1 1 9 Q&A Q A 10 1 1 2 1 11 1 2 3 12 1 1 2 3 1 2 1 13 Q&A Q A 14 1 1 2 1 2 1 15 1 2 3 4 5 16 1 1 2 3 1 2 1 17 1 2 3 18 1 1 2 3 1 2 1 2 1 19 Q&A Q A

NL09

Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

437“ƒ

et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

Msx2

201204_“LŁñ_166.indd

untitled

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J

アニサキスの刺入を内視鏡的に確認し得た上行結腸癌の1例　第54巻05号1656頁

エイズ抄録_修正済1027.idd

Uenishi Rie Biochemistry Laboratory, Institute of Plant Breeding, University of the Philippines Los Banos Experimental Retrovirology Section HIV and AIDS Malignancy Branch, National Cancer Institute,

第16回　日本乳癌会

MMG MMG MMG MMG 1. cm cm 超音波検診で乳癌死を減らすために ３ １ ３ 人に止まるはずである すな を比較した場合 １ mm のものは５mm のものの わ ち 現 在 の 乳 癌 死１ 人 の う ち の１ ４倍の面積を有するからである よっ １ ３ ４ 人が救命される計算となる いいか て 検診の現場において見逃してはいけない腫瘤 えれば乳癌死を約３分の１に減らすことが可能で

NL10

Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

1

Carcinogenic potential TG-GATEs Prediction Score < 0 : Negative 0 < Prediction Score : Positive Analyzer 3 h 6 h 9 h 24h 4 d 8 d 15d 29d Single Repeated DataBase Predictor PNAS 2008 Exp Eye Res 2010

14-2JAMTTCNL0913F

JAMTTC News Letter No.14-2 Sept. 2010 http://jamttc.umin.jp Japanese Association for Molecular Target Therapy of Cancer information September, 2010 1 News 2 Japanese Association for Molecular Target Therapy

第79回_プログラム.indd

Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial

RAD-AR News Vol.12, No.1 (May 2001) 2

RISK / BENEFIT ASSESSMENT OF DRUGS-ANALYSIS & RESPONSE RAD-AR Series No.44 2 3 5 8 9 10 11 12 14 15 16 19 20 RAD-AR News Vol.12, No.1 (May 2001) 2 3 RAD-AR News Vol.12, No.1 (May 2001) 4 5 RAD-AR News

untitled

A Special Talk 2003 1 21 2003 1 21 櫛 May 2004 The first year activity of the forum : Embedded Linux Specification http://celinuxforum.org/docs/celf_specification_v_1_0_r1-1.pdf https://lkml.org/lkml/2004/5/17/149

NL11

information September, 2007 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11 September, 2007 3 2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Journal Physiology, American Journal of Physiology, Journal of Physiology, Journal of Autonomic Nervous System, American Journal of Physiology,

x_rename ファイル名変更／移動／コピー

1....1 1.1....2 1.2....5 1.3....6 1.4....8 1.5.... 10 2.... 12 2.1.... 12 2.2.... 16 2.3.... 22 2.4.... 24 2.5.... 25 2.6.... 27 2.7.... 31 2.8.... 33 2.9.... 38 2.10.... 40 3.... 43 3.1. &... 43 3.2....

H1_4

HANSHIN CANCER CONFERENCE 04 No. Issue : July 2015 Journal of Kansai Rosai Hospital Cancer Center 2 Message 7 9 11 13 2 3 5 21 23 25 26 15 17 19 Contents Facility 3 4 肺 疾 患 上 気 道 疾 患 閉 塞 性 換 気 障 害 :COPDなど

根治的手術を施行し得た同時性重複癌 ( 進展舌癌と食道 Title 癌 ) の1 例 千葉, 哲彦 ; 岩本, 昌士 ; 齊藤, シオン ; 八木澤, 潤子 ; Author(s) 野本, 俊太郎 ; 市川, 秀樹 ; 成田, 真人 ; 伊藤, 亜希 ; 松崎, 英雄 ; 田中, 潤一 ; 髙野, 伸夫 Journal 歯科学報, 109(2): 192-200 URL http://hdl.handle.net/10130/912

表1.eps

Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol

笑いの効果ー脳にどんな影響をもたらすか

37 NPO NPO OECD Health Data 2005 WHO WHO ( ) J@pan Inc 3 3 2002123 410 1 GNP13.5 50 AHA News Oct.28,1992 3 07.7 2007 31 11 26 1 47.35 2 5.91 3 5.81 63 1.95 192 0.02 10 14 OECD 290 206 127.6 1999 50 (OECD)

03 06 17 18 20 22 24 26 27 28 29 30 33 34 35

03 06 17 18 20 22 24 26 27 28 29 30 33 34 35 07 01 08 02 09 03 10 04 11 05 12 06 13 07 14 08 15 09 16 10 - Teenage Cancer Trust www.teenagecancertrust.org. - CanTeen, Australia www.canteen.org.au. - CanTeen,

1. 1 1 1 2 2 3 4 2. 6 1 6 2 6 3 7 3. 8 1 8 2 9 4. 10 1 10 2 11 3 12 5. 14 15

がんと 療 養 202 1. 1 1 1 2 2 3 4 2. 6 1 6 2 6 3 7 3. 8 1 8 2 9 4. 10 1 10 2 11 3 12 5. 14 15 がんと 心 1 1. 1 1 がんの 冊 子 がんと 心 2 2 01 がんと 心 3 がんの 冊 子 がんと 心 3 4 01 がんと 心 5 がんの 冊 子 がんと 心 2. 1 2 6 02 心 のケア 3 7 がんの

untitled

PS3 10% 2-1 2-2 2-3 2 23 2-4 1 2 3 4 2-5 2.3.1 1 24 812 2-6 5 5% : (CVC) 5 2-7 CTZ 24 24 2-8 2.3.2 23 5HT3 12 2-9 2.3.3 12 12 23 710 13 5-FU 2-10 2.3.4 24 10 20 5-FU 2-11 2-12 (CTZ) 5HT3 H1 Achm (CTZ)

06-24 44-59 CSR 25-43 2015 60-175 CSR 151 176-186 26.2% 4.1 7.3% 6.6% 2,327 1 42.9% 17.0% 1 1375199 2015 4 1 5 5 1 2 3

06-24 44-59 CSR 25-43 2015 60-175 CSR 150 176-186 2014 2014 CSR 2015 4 1 5 2,327 5 2014 CSR 2012 12 5 1112 201452,327 06-24 44-59 CSR 25-43 2015 60-175 CSR 151 176-186 26.2% 4.1 7.3% 6.6% 2,327 1 42.9%

untitled

Eternit IAS TAS 2006 11 2007 12 1 TNS TNS 1960 80 2 3.5 1975 Eternit 1993 1989 92 200 300 400 50 37.0 40.5 1940 111940 241950 381960 201970 61970 Eternit Goor 15 6 2006 11 VROM 400 120 2017 490 IAS TAS

1) Lieberman, P.: Some Acoustic Measures of the Fundamental Periodicity of Normal and Pathologic Larynges. J.A.S.A., 35 : 344, 1963. 2) Koike, Y.: Vowel Amplitude Modulations in Patients with Laryngeal

untitled

13 13 2014 3 1415 TEL.0859-33-3531 / FAX.0859-33-3607 TEL 0859-38-6292 FAX 0859-38-6293 E-mail: gan-center@med.tottori-u.ac.jp 13 13 Department of Medical Oncology, Thomas Jefferson University) 1F 2F

2

The Japanese Division of the lnternational Academy of Pathology Published quarterly by the Japanese Division of the International Academy of Pathology 2016 Number 1 OFFICERS PRESIDENT R. Katoh, M.D. (

Professor of Epidemiology and Nutrition, Harvard School of Public Health Personal History 1945 Born in Hart, Michigan, USA 1970 M.D. University of Mic

The Search for Optimal Diets: A Progress Report Commemorative Lecture at the Twenty-Fifth Honda Prize Awarding Ceremony on the 17th November 2004 in Tokyo Walter C. Willett Professor of Epidemiology and

転移を認めた 転移率は 13~80% であった 立細胞株をヌードマウス皮下で ~1l 増殖させ, その組

Title Author(s) Citation Issue date 1997-12 Resource Type Resource Version URL Kobe University Repository : Kernel ヒト口腔扁平上皮癌細胞および組織片のヌードマウス舌への同所性移植による浸潤 リンパ節転移に関する実験的研究 (Experimental study of invasion

胃癌診療 -内視鏡治療と予防の最前線-

K net 21 5 28 10-20 5 100 32 K net 19 1 18 - - K net 21 5 28 2 2 RCT LECS NOTES 19 2 Narrow Band Imaging Light Penetration Depth Light penetration depth within the tissue highly depends on the wavelength.

2006

2006.11.25 92 1869 H 92 U 19 1895 X 1896. 20 92 X X 1 ev DNA ev DNA DNA 300 28 JCO 1999 9 JCO DNA 1934 66 X X 15 40 2 2.4 3 BEIR-VII 0.01 50 50 0.5 100 0.5 5000 30 1.6 2.25 2.25 1000 0.2 0.1 2000 10 245

untitled

260 250 200 150 10 100 50 0 1960 1965 1970 1975 1980 1985 1985 1995 2000 2005 25% 56% 66% 60% 90 80 70 60 50 40 30 20 10 0 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1999 1990 2003 2005 2010 500,000 70,000 100,000

Establishment and progress of Sendai virus engineering 2) Schnell, M. J., Mebatsion, T., Conzelmann, K.-K.: EMBO J., 13,4195-4203(1994) 3) Kato, A. et al.: Genes Cells, 1, 569-579 (1996) 4) Nagai,

- 108 -

3-107- - 108 - 3.1 3.1.1 3.1.2 3.1.2.1 5 LD50 LC50 ATE 3.1.1 1 2 3 4 5 (mg kg ) 5 50 300 2000 5000 a (mg kg ) 50 200 1000 2000 a (ppm) 100 500 2500 5000 a b mg 0.5 2.0 10 20 a b c d 0.05 0.5 1.0 5 (mg

P r o g M e d suppl ProgressinMedicineVolsuppl. 第９回アミオダロン研究会講演集 12月3日 12月4日 12月6日 12月25日 12月8日 2004年1月5日 図５ 胸部X線とCTの経過 図６ 退院７カ月後の胸部X線写真とCT ２００ ４年８月 期に行う必要があった 最終的には マイコプラズマ抗体が５１ ２倍と著増し ており ペニシリン系抗生物質およびミノサイクリン

肺癌第49巻第1号

1 Department of Diagnostic Pathology, Graduate School of edicine, Chiba University, Japan; 2 Department of Thoracic Surgery, Chiba Rosai Hospital, Japan; 3 Work Environment Research Group, National Institute

星医会00表紙.pdf

H A,, , ,,, Facebook PSP PSP in situ hybridization New York Bronx Veterans Administration Hospital, Alcohol Research and Treatment Center demanding education e-ducare S. M. McCann Proc. Natl. Acad.

<95AA8E718CA4838C835E815B835937308D862E696E6464>

New Lab 1996 19982001 ( ) 2001 20032007 2014 4 2014 26 4 1 UVSOR 10 2~4 2 KIT 70 September 2014 23 24 70 September 2014 New Lab 1995 1997 2000 2003 2000-2005 JST-ERATO 2005-2011 2011-2014 2014 6 2014 6

untitled

2003 300 2015 500 2015 2006 quality of lifeqol 2012 2016 5 research guideline training practice 4 QOL QOL 2013 3 7 1 8 2 8 1 22 23 2 3 3 47 1 2 3 4. 49 1 50 2 51 1 2 3 4 3 73 1 2 3 4 5 87 1 88 2 88 1 2

外来化学療法を受けるがん患者のケアプログラム試案の作成 患者の困難や苦悩とニーズに焦点を当てて 1 2 2 Abstract A purpose of this study is to develop the tentative care program of cancer out-patients undergoing chemotherapy. We did the literature reviews

奈良県立医科大学耳鼻咽喉・頭頸部外科学-2017年Facebookページ記事.pages

2017 1 1 ( ) 6:10 UTC+09 Tadashi Kitahara 11 2017 1 14 ( ) 0:15 UTC+09 Thuy Hien Dao Hien Hien 2 5 2017 1 18 ( ) 18:20 UTC+09 Dr. Do Tuan Hung Hung 2017 1 20 ( ) 18:54 UTC+09 2 ( 5 ) 6 ( 6 ) 2 2017 1 21

indd

Molecular Targeted Therapy for Lung Cancer from a Pharmaceutical Point of Viewe Naho SASAKI epidermal growth factor receptor tyrosine kinase inhibitor :EGFR-TKI vascular endothelial growth factor:vegf

No.10

Unio Internationalis Contra Cancrum International Union Against Cancer UICC UICC 2009.4 1 UICC News Letter No.10 2 2009.4 3 UICC News Letter No.10 4 2009.4 5 UICC News Letter No.10 6 The fight against

2 21 211,,, (Hz), AM (1MHz), 300m, 24 (245GHz), 12cm, 212 (electromagnetic fields), (electromagnetic radiations) (NIR),X,,,, RF, ELF,,, 22 221,, 2005

1 2003 6 7500 2 1 1 1 WHO, IARC, 2004 2 1973 1993 16 1997 SAR 2002 6, SAR 2W/kg, WHO ICNIRP 2 21 211,,, (Hz), AM (1MHz), 300m, 24 (245GHz), 12cm, 212 (electromagnetic fields), (electromagnetic radiations)

~EW c~ tologic mucol~ア tic 110\\ ada~ s wide!~ employed flexibilit~' rigidit~ mm~

THE TRIALS IN THE CYTOLOGICAL GASTRIC CANCER : PART I NEW DIAGN BALLOON TitleTECHNIQUE "ABRASIVE BALLOON IN THE CYTOLOGICAL DIAGNOSIS WITH A OF GAS CANCER Author(s) YOSHIDA, YOSHIYUKI Citation 日 本 外 科

<91E F193FA967B97D58FB B2D8FB4985E8F572E696E6464>

36 35 12 10 4 1 1300 1330 26 10 5 1 1330 1400 26 10 4 1 1400 1430 10 5 1 1400 1430 10 4 1 1430 1530 1 10 5 1 1430 1530 2 10 4 1 1100 1130 EL-1 1 10 4 2 1100 1130 EL-2 2 10 4 2 1500 1530 EL-3 3 2015 10

untitled

R R R 2 R 2 R R R R R R R R R R 3 R R 4 R C JAVA 5 R EXCEL GUI 6 R SAS SPSS 7 R 8 R EXCEL GUI R GUI RR Commander 9 R Auckland Ross Ihaka Robert Gentleman Fred Hutchinson Cancer Research Center AT&T Lucent

GB 3rd edition final.ppt

Complementary and Alternative Medicine (National Center for Complementary and Alternative Medicine; NCCAM) Complementary and alternative medicine is a group of diverse medical and health care systems,

2003 Giemsa HE HE AE1+AE3 HBME1 HE HE Well differentiated adenocarcinoma of colon Giemsa HE HE 62 Group V HE 47 Group V Peritoneal dissemination of gastric cancer HE 51 Poorly differentiated Adenocarcinoma(por2)

終末期癌患者に対する 輸液治療の是非

3 A B NSAID D Case stories A B NSAID D Case stories A. IASP Task Force on Taxonomy WHO Collaborating Center for Palliative Cancer Care : Looking forward to cancer pain relief for all. CBC Oxford, Oxford,

************************************************************************************** ***************************************************************

************************************************************************************** ************************************************************************************* (4 ID 12 16 110 900 17 00 1

第５７巻２号／投稿規定・目次・表２・奥付・背

Feature articlesdiet in a society with a growing elderly population and a low birth rate Original The problems of breastfeeding Kazuhisa Maeda, Ryuji Mitani, Satoko Endo, Yoshika Saijo, and Toshihiro

t Uhlenhaut NH, Jakob S,Anlag K, et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell. 2009;139(6): ll3o-42. 2 Chalvardjian A, Scully RE. Sclerosing stromal tumors of

Rinku General Medical Center

Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9

32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5

BTR 6110BTR CTC CTC CTC-HER2-1 -

0-1. 6110BTR 6110BTR CTC CTC CTC-HER2-1 - 0-2. 0-3. 0-4. 0-5. 0-6. 0-7. - 2 - - 3-0-8. tsurutani_j@dotd.med.kindai.ac.jp ykodera@med.kindai.ac.jp ...- 1-0-1.... - 1-0-2....- 2-0-3....- 2-0-4....- 2-0-5....-

奈良県立医科大学耳鼻咽喉・頭頸部外科学-2016年Facebookページ記事.pages

2016 1 10 ( ) 1:22 UTC+09 52 2016 1 10 ( ) 1:30 UTC+09 70 2016 1 10 ( ) 10:15 UTC+09 2016 1 10 ( ) 13:29 UTC+09 70 Lucky Cat 2016 1 15 ( ) 18:54 UTC+09 2 ( 5 ) 5 ( 6 ) 7 2016 1 29 ( ) 17:55 UTC+09 2 (

untitled

1890 Thomas L. Walden, Jr. PhD, Radiology 1991; 181:635-639 Thomas L. Walden, Jr. PhD, Radiology 1991; 181:635-639 (1) 1890 1895 118 X 1896 2 18961 2 (2) 1896 1897 X X130 (3) 1900 1905 X X1900 1920, 30,

2005 6 7 15 2006 3 shokuiku shokuiku 2

2005 6 7 15 2006 3 shokuiku shokuiku 2 shokuiku 3 (shokuiku) (shokuiku) (shokuiku) (shokuiku) 4 ( ) 2005 7 15 2006 4 5 shokuiku shokuiku 1 2 3 shokuiku shokuiku shokuiku 6 1 ( ) 15~64 1992 65 2050 40%

123 1990 19971992 2003 124 1999a 2003 3 1998 1999b 2 2003 1 200 Fredrickson 2001 2006 2008 2000 19901993 12 30 2 2003 1 181 2 37 201 174 18.4 0.7 6 3 7 2 23 611 3 1 20 3 4 4 126 1999 3 3 1 3 6 0 00 Watson

紀要　No,2

2003 79 84 Memoirs Kyushu U. Sch. Health Sci., 2003 vol.2 79 84 79 Miyako Oike The purpose of this study was to examine case studies of 3 cancer patients from a viewpoint of narrative and emplotment, and

平成１３年度内分泌攪乱化学物質のヒトへの健康影響調査研究報告書

. 1,3 4 5. 1 2 NB-1 MCF7 MEIC 1-3 4-6 NB-1 JCRB Japan Cancer Research Bank MCF ATCCAmerican Type Culture Collection 2 19994 212 11 PVDF.22µm 8 2 11 4 4 3 5 1 4 cellsml -1 96 4,6 NB-1 48 MCF7 24 4 5 48

:†zEdian

October p p QOLQuality of life Spirituality QOL End of life Care Wolf p p Spinetta, Rigler, Karon, p Davies p October p p p p p WHO QOL Cancer Palliative Care WHO WHO, WHO spiritual p transcendence Anbacken

Single slice helical CT CT 1 2005 1 4 1. CT Anti-Lung Cancer Association: ALCA 1-5) 1993 9 10 ALCA (Nawa 6) ) single slice helical CT 10mm CT 2. 1 (http://www.thoracic-ctscreening.org/jpn/index.html )

表紙69-5,6_v10.eps

２ １ ６ 宇佐美 眞 他 に対応する管理を行う３ ４ 癌と栄養代謝 悪液質 cachexia とその前段階の前悪液質 precachexia は 図２に示す体重減少と BMI の変化 サルコペニア の有無 食欲不振と代謝変化によって定義されている３ 悪液質は 腫瘍の種類と存在部位により極めて多様な 病態を呈するが その病態は図３の様に 代謝変化臓器 として骨格筋減少 サルコペニア が中心におかれて理

<4D F736F F D208C9F8DF58C8B89CA82CC90E096BE2E646F6378>

バセドウ病治療ガイドライン [1] 初回検索 CQ1 妊娠初期における薬物治療は 第一選択は何が推奨されるか? 検索結果 :( ファイル名 :CQ01-PubMed-v1.xlsm) 1) メタアナリシス システマティックレビュー 診療ガイドライン 34 件 (Sheet1) 2) 臨床研究 ( ランダム化比較試験含む ) 7 件 (Sheet2) 上記との重複除く 3) 疫学研究 192 件 (Sheet3)

（プロ1特別企画用ショート版） （詳細頁レ）.indd

Professor, Department of Cardiovascular Medicine Graduate School of Medicine and Faculty of Medicine, The University of Tokyo Ryozo Nagai Former Senior Clinical Advisor, Centers for Medicare & Medicaid

HPV HPV HPV HPV 7 HPV 8 9 HPV 3 HPV HPV HPV , Becker Ajzen H

3 26 3 Journal of Junshin Gakuen University, HPV Faculty of Health Sciences Vol.3, March 2014 99 HPV Knowledge of and attitudes towards human papillomavirus vaccinations among mothers who have daughters

E3200 BV FOLFOX4 FOLFOX4 PFS % 0.42, 0.65 p< log-rank % FOLFOX4 8.6% FOLFOX % FOLFOX4 259/ % FOL

E3200 BV FOLFOX4 FOLFOX4 PFS 4.5 7.5 0.518 95% 0.42, 0.65 p

【日本放射線技術学会北海道部会メールマガジン 125号 2014/05/30 】

125 vol.125 2014/05/30 reader 42 Ambitious 2014 - make the next frontier, make the new future - [ ] 2014 10 9 ( ) 11 ( ) [ ] 003-0006 6 1 1-1 TEL 011-817-1010 [ ] ( ) ( ) [ ] ( ) [ ] 26 4 25 ( ) 6 1 (

II) SIR SMR)

II) ) 6 55 95 95Confidence Interval; 95CI) confidence intervals 95 95 1 5 95CI.66 Mortality experience of cockpit crewmembers from Japan Airlines. Kaji M, Tango T, Asukata I, Tajima N, Yamamoto K, Yamamoto

P1

NEWS REPORT カロリンスカ大学との合同シンポジウムJapanese-European Joint Symposium on Ion Cancer Therapy& NIRS-KI Joint Symposium on Ion-Radiation Sciencesに参加して 写真1 カロリンスカ大学との合同シンポジウム参加者 重粒子医科学センター物理工学部治療システム開発室 松藤 成弘 写真2

長崎Edwards

BMJ 1997; 315: 909-15 Esophageal Doppler FTc > 0.35 Protocol (1997) Esophageal Doppler GDT Anesthesiology 2002; 97: 820-6 Major surgery Esophageal Doppler FTc >0.35 GDT PONV LOSGDT5 vs 7 6% hetastarchgoal

or or 100,261 76.96 55.04 18,234 77.55 58.74 12,150 57.27 25.25 14,354 95.12 81.69 8,270 92.38 79.36 4,168 84.82 58.88 5,569 83.80 61.55 4,204 55.48 19.57 11,671 25.3 6.7 5 5 10 12 10 1 10 9 30 10

lhr) STRENSIQ@ Subcutaneous Injection 7^rrr-E 7tv77 (ilffi#&i) slfrj 18mg 4044q', r12.9, 110.8' -2. l9:t1.33bl (n{) E 7/\7t 7> iof 0) H5fr (mg) t)7;tl 'rd LDV O) *4n (ms) SOF O) *5t (mg) /^L'ltr")1

PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article 1 1. 2. MeSH Browser MeSH PreMEDLINE MeSH -2-

PubMed MEDLINE NLM 1879 Index Medicus 1960 MEDLARS Medical Literature Analysis and Retrieval System 1970 MEDLINE MEDlars online 1966 70 4,000 170 PubMed MEDLINE NLM National Center for Biotechnology Information

untitled

PART 14 1974 7 31 1 2001 21 by 2001 4 10 18 5000!! by 1 20 20 1 20 by!!! 2 1 7 by 3 6 Lobular endocervical glandular hyperplasia LEGH CT MRI (1,2) (3 7) LEGH LEGH LEGH 6) LEGH LEGH 3000 1 LEGH LEGH LEGH

gofman2.eps

2011 7 10 4 7 1 ICRP(2007) 5.7 10 2 Sv 1 1 13 (=4600 =11 =660 ) 10mSv 5.7 10 4 4600[] =2.6[] ICRP 0 1 licrp 1 2 1 DDREF ICRP(2007) (ICRP 2007, p.178) - (idem., p.174) 1Sv - (DDREF: dose and dose-rate effectiveness

Vol. 41 1 2 4 5 9 10 14 18 21 23 24 26 26 27 28 29 30 32 32 33 34 36 1 2 3 4 5 0 2 4 6 8 10 12 14 0 2 4 6 8 10 12 14 16 18 0 1 2 3 4 5 6 7 8 9 0 5 10 15 20 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

untitled

( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m

レントゲン X線

PET ( TIAN Mei ) PET 100 PET PET PET PET PET Positron Emission Tomography (PET) PET Positron Emission Tomography CT PET FDG Glucose and 18 F-FDG 18 F-FDGFDG CH3OH O CH3OH O OH OH OH OH OH OH OH 18 F *FDG

Microsoft Word - 2012.03.12塩路修正済編集.docx

1 2012 2 ICRP 1 1 100 (msv) 2 2 1920 1930 [Muller, 1936] ICRP ICRP 1950 3 100 (msv) I. 1950 OSCC 1957 International Commission on Radiological Protection 2 (Sv) Sv 1000 S ( ) 5mSv 100% ICRP UNSCEAR 3 1997

1974 259210 1983

2007.7.1 No. 22 京都外国語大学校友会 1974 259210 1983 1 2007 221 60 60 60 1860 60 4537 12 6045 222 1 2007 200751860 45 60 60 6060 1947 60 223 1 2007 194722 60 2005 2 414020 3 18 16 60 20093 5 199411 13 197633 100

小児感染免疫第23巻第1号

Vol. 23No. 163 42 HPV HPV 1113 HPV 42 HPV HPV HPV 1 1 510 1020 HPV 1020 510 HIV 0.1 0.005 HIV 2030 HIV 0.2 510 HPV 1020 15 HIV 2030 HIV HIV 0.2 0.1 Takeyuki Sato 2608677 181 64 2011 2 1 1518 6,000 513

untitled

CONTENTS 01 02-03 04-05 06-07 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 48-49 50-51 52 01 02 Mishima,Michiaki 03 04 05 06 07 09 10 11

untitled

1960 193040 193040 1 0.05 25 16 6 7 109 5 6 30 7 311 10 1 P.G. Harries. Asbestos dust concentration in ship repairing: A practical approach to improving asbestos hygiene in naval dockyards, Ann

- 9 91, (2006)

Case study level Ma Management of testicular cancer - 9 91, 10 0.7 2.4 (2006) 20 30 20 20-40 AFP -hcg -hcg AFP TNM T ptx pt0 ptis pt1 / pt2 / pt3 / pt4 / N NX N0 N1 2cm 1 2cm N2 2cm 5cm 1 5cm N3 5cm TNM

<4D F736F F D20342D D834F DA8E9F5F8AAE97B95F>

H. pylori S1-1 Hp S1-2 H. pylori S1-3 S1-4 75 Helicobacter pylori () S1-5 S1-6 Helicobacter pylori S1-7 H. pylori () S1-8 Helicobacter pylori () : H. pylori S2-1 H. pylori Ferric uptake regulator(fur)

化学療法剤の適切な使い方について

1 2 3 4 5 6 7 Che E, in Cancer: Principles & Practice of Oncology (7th ed) in Devita, 2005 Marangolo M, Oncol Rep, 2006 hryniuk WM, Important Adv Oncol, 1988 8 Cancer: Principles & Practice of Oncology

R Commanderを用いたデータ解析

1 / 82 R Commander Kengo NAGASHIMA Laboratory of Biostatistics, Department of Parmaceutical Technochemistry, Josai University 2010 1 5 R R Commander 2 / 82 R, "The Comprehensive R Archive Network (CRAN)",

SICE東北支部研究集会資料（2017年）

307 (2017.2.27) 307-8 Deep Convolutional Neural Network X Detecting Masses in Mammograms Based on Transfer Learning of A Deep Convolutional Neural Network Shintaro Suzuki, Xiaoyong Zhang, Noriyasu Homma,

3 6 6 8 5 5 0 4 3 4 4 0,000 3 ID ID ID 4 7 9 :5 4 5 60-8048 NACOS TEL: 075-45-366 FAX: 075-45-366 E-mail: jiao@nacos.com 3. Power Point PC 0 5. Power Point PC 7 3 3. 3 5 PC PC PC Windows Power Point USB